Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer [Phase 1]
A completed Phase 1 trial evaluating the safety of combining SB-485232 (interleukin-18) with Doxil (liposomal doxorubicin) in advanced epith…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer [Phase 1]
This update reports that ThermalCore Inc.'s Phase 1 trial of Perfusion Induced Systemic Hyperthermia for terminal ovarian cancer is suspende…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients [Phase 2]
A Phase 2 trial evaluated the feasibility of performing interval debulking surgery via laparoscopy for chemosensitive peritoneal carcinomato…
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Detection of Chlamydia DNA by Polymerase Chain Reaction in Primary Tubal and Ovarian Cancers Tissues : a Pilot Study
A pilot clinical trial update evaluating whether Chlamydia DNA can be detected by PCR in tissues from primary fallopian tube cancers and ova…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
The document reports the completion of a Phase 2 clinical trial evaluating Karenitecin for persistent or recurrent ovarian epithelial cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial CT-2103 for recurrent or persistent ovarian epithelial cancer or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2017-07-13Clinical Trial Update: Toremifene in Treating Patients With Ovarian Cancer [Phase 2]
This clinical trial update reports that the Phase 2 study of toremifene for ovarian cancer sponsored by George Washington University has bee…
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with or without fosbretabulin tromethamine in recurrent or persistent ovarian epithelial, fallopian tub…
-
FDA approval · 2017-07-06FDA Approved: TOPOTECAN — Original Application (Accord Healthcare Inc.)
The FDA approved Accord Healthcare Inc.'s original application for a generic Topotecan. This approval makes a generic version of Topotecan a…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer [Phase 2]
Phase II trial evaluating bevacizumab followed by consolidation therapy for advanced ovarian cancer and related tumors; results have been po…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Microarray Analysis for Human Genetic Disease
This clinical trial update notes the completed status of a National Human Genome Research Institute–sponsored microarray analysis study in h…
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors [Phase 1]
A Phase 1 trial evaluating CT-011 and a p53 genetic vaccine for advanced solid tumors was withdrawn; the study encompassed breast cancer, co…
-
CLINICAL_TRIALS research · 2017-06-22Clinical Trial Update: Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating PM01183 in combination with Olaparib for advanced solid tumors, including ovarian, endometrial, and brea…
-
CLINICAL_TRIALS trial_result · 2017-06-15Clinical Trial Update: Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer [Phase 1, Phase 2]
A two-arm Phase 1/2a dose-escalation study of BAX69 in patients with malignant ascites due to refractory ovarian cancer has been terminated …
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer [Phase 2]
A Phase 2 trial conducted by GlaxoSmithKline evaluating a second-line intravenous therapy for recurrent platinum-sensitive ovarian, fallopia…
-
CLINICAL_TRIALS trial_result · 2017-06-07Clinical Trial Update: Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian Cancer [Phase 1]
Phase 1 trial update evaluating the safety and pharmacokinetics of escalating doses of DNIB0600A in participants with non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Assess Bioequivalence of Two Formulations of Doxorubicin Hydrochloride Liposome in Female Patients With Ovarian Cancer [Phase 1]
Phase 1 trial completed evaluating bioequivalence between two formulations of liposomal doxorubicin in female patients with ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Advanced Ovarian Cancer and Sexuality Phase 1
Phase 1 clinical trial from the University of British Columbia evaluating advanced ovarian cancer and sexuality has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer [NA]
Completed efficacy trial evaluating FloSeal for prevention of lymphocele after lymphadenectomy in gynecologic cancer.
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer
Clinical trial update notes neutropenia observed in patients with epithelial ovarian cancer receiving adjuvant paclitaxel/carboplatin chemot…
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian Cancer [Phase 2]
The update notes that a Phase 2 efficacy study evaluating neoadjuvant chemotherapy for advanced ovarian cancer has completed.
-
CLINICAL_TRIALS research · 2017-05-30Clinical Trial Update: Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer [NA]
The completed clinical trial evaluated whether yoga helps manage symptoms and reduce stress in women with breast cancer or ovarian cancer. I…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of RO4929097 in recurrent/metastatic epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer has compl…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: BMN 673 (Talazoparib), an Oral PARP Inhibitor, in People With Deleterious BRCA1/2 Mutation-Associated Ovarian Cancer Who Have Had Prior PARP Inhibitor Treatment [Phase 2]
Phase 2 trial evaluating BMN 673 (talazoparib), an oral PARP inhibitor, in ovarian cancer patients with deleterious BRCA1/2 mutations who pr…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma [Phase 2]
A Phase 2 feasibility trial evaluating intraperitoneal chemotherapy for ovarian, fallopian tube, and primary peritoneal carcinomas has been …